Literature DB >> 23453337

Multimodality approach to management of stage III non-small cell lung cancer.

Anthony Scarpaci1, Priya Mitra, Doraid Jarrar, Gregory A Masters.   

Abstract

Stage III non-small cell lung cancer represents a heterogeneous group of patients who are best managed with a multidisciplinary approach, including evaluation for surgical, radiation, and chemotherapeutic options.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2013        PMID： 23453337     DOI： 10.1016/j.soc.2012.12.014

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  4 in total

1.  Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities.

Authors:  Shervin M Shirvani; Jing Jiang; Daniel R Gomez; Joe Y Chang; Thomas A Buchholz; Benjamin D Smith
Journal:  Lung Cancer       Date:  2013-08-21       Impact factor: 5.705

2.  USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1.

Authors:  Deepa Kushwaha; Colin O'Leary; Kyle R Cron; Peter Deraska; Kaya Zhu; Alan D D'Andrea; David Kozono
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

3.  Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity.

Authors:  Marina Cardó-Vila; Serena Marchiò; Masanori Sato; Fernanda I Staquicini; Tracey L Smith; Julianna K Bronk; Guosheng Yin; Amado J Zurita; Menghong Sun; Carmen Behrens; Richard L Sidman; J Jack Lee; Waun K Hong; Ignacio I Wistuba; Wadih Arap; Renata Pasqualini
Journal:  Am J Pathol       Date:  2016-06-16       Impact factor: 4.307

4.  NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair.

Authors:  Peter V Deraska; Colin O'Leary; Hunter D Reavis; Shelby Labe; Tru-Khang Dinh; Jean-Bernard Lazaro; Christopher Sweeney; Alan D D'Andrea; David Kozono
Journal:  Cell Death Discov       Date:  2018-02-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.